In a piece for USA Today, Mark Olalde reports on a new study of municipal politics co-written by MIT Professor Chris Warshaw. Through the study, which examined the political preferences of U.S. residents in specific cities, Warshaw found that Mesa, Arizona was the most conservative city and San Francisco, California the most liberal.
The Economist highlights a new study by Prof. Chris Warshaw that analyzed how accurately the policies of local leaders reflect their constituents’ views. “They found that the most ideologically liberal cities end up spending twice per capita as much as the most conservative cities, have higher taxes and less regressive tax systems,” The Economist reports.
Sam Sturgis of CityLab examines a new study by MIT Professor Chris Warshaw that shows that municipal governments, regardless of their structure, tend to mirror the ideological preferences of their electorate. The researchers, “aggregated a collection of nationwide survey results to determine the political leanings of 1,600 U.S. cities and towns,” Sturgis writes.
Professor Kenneth Oye speaks with WBUR’s Sacha Pfeiffer about his recent research that details a new way to alter the genomes of organisms and the need for a public discussion about the potential implications and benefits of this new technology.
Wall Street Journal reporter Ed Silverman interviews Professor Andrew Lo about his proposal that a public-private partnership could solve funding issues for drugs research and development. “Right now, the risk of failure [in developing an Alzheimer’s treatment] is far too high for any single pharmaceutical company to take on,” Lo explains.
Jeffrey Brown of the PBS News Hour speaks with Professor Craig Wilder about the recent $40 million settlement received by five black and Latino men wrongly convicted of rape and assault in New York City 25 years ago.
“Based on the current rates of success in creating new drugs for Alzheimer's disease, it could take 260 years until the next one is approved,” writes The Boston Globe’s Carolyn Johnson on the rationale for why Professor Andrew Lo is proposing a new, portfolio-based approach to Alzheimer's research.